Shanghai Electric (SEHK:2727, SSE:601727) ("the Company") discussed the long-term cooperation opportunity with Siemens to boost technological innovation in the healthcare and energy sectors in a recent visit paid by the top executives from Siemens Healthineers and Siemens Energy....
Harnessing Hitachi's automated cell culturing and digital technology to overcome intractable diseases...
Over 50% of Thai children currently suffer from tooth decay, and more than 60% of adults suffer from gingivitis...
Skanska has signed a contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA. The contract amendment is worth USD 91M, about SEK 1.0 billion, which will be included in the US order bookings for the second quarter of 2023....
Getinge announces clearance from the US FDA for Servo-air® Lite, a wall gas independent non-invasive mechanical ventilator....
BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an inte...
Genesis MedTech, a leading medical device company, announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release....
Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo® Heart Failure. HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF). HCPCS code C9786 can now be used for billing artificial intell...
The wearable ultrasound imaging solution combines the wireless freedom of Clarius ultrasound with the security of the ProbeFix Dynamic, enabling limitless research opportunities of bodies in motion....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]...